Wird geladen...
Multiple myeloma: the (r)evolution of current therapy and a glance into the future
Over the past 20 years, the regulatory approval of several novel agents to treat multiple myeloma (MM) has prolonged median patient survival from 3 to 8-10 years. Increased understanding of MM biology has led to advances in diagnosis, prognosis, and response assessment, and has informed the developm...
Gespeichert in:
| Veröffentlicht in: | Haematologica |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Fondazione Ferrata Storti
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7556665/ https://ncbi.nlm.nih.gov/pubmed/33054076 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3324/haematol.2020.247015 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|